HbA1c as screening biomarker of dyslipidemia in Type 2 Diabetes mellitus patients

Journal Title: Scholars Journal of Applied Medical Sciences - Year 2016, Vol 4, Issue 5

Abstract

Type 2 diabetes mellitus consists of an array of dysfunctions characterized by hyperglycemia and resulting from the combination of resistance to insulin action, inadequate insulin secretion, and excessive or inappropriate glucagon secretion. The A1C test is a blood test that provides information about a person’s average levels of blood glucose, also called blood sugar, over the past 3 months. The Aim is to study roll of HbA1c as screening biomarker of dyslipidemia in Type 2 Diabetes mellitus patients. The Study consists of 120 type 2 DM patients of 40-70 year age group along with age and sex matched healthy control. Fasting Blood samples were collected from all participants for measurement of Lipid profile, Blood sugar (FBS) and HbA1c. In case group, the mean concentration of Fasting blood glucose(mg/dl), S.Cholestrol (mg/dl), S.Triglyceride (mg/dl), S.HDL(mg/dl) and HbA1c(%) is 138.5±5.2, 265±10.5, 210.9±5.2, 38.6±6.3 and 10.6±1.0. Respectively while in control group it is 85.6±6, 156.9±8.5, 119.5±7.3, 44.5±3.2 and 5.2±0.5 respectively. The HbA1C might be used as a reliable biomarker in the screening of dyslipidemia in diabetes type-2 patients because it showed positive correlation with TC, TG, VLDL, and LDL-C but negative correlation with HDL-C. Keywords: HbA1c, dyslipidemia Type 2 Diabetes mellitus

Authors and Affiliations

Dr Rajul Lodha, Dr Renuka Z Lal, Dr Shweta Biyani

Keywords

Related Articles

Acute Vision Loss: Aetiology, Clinical Profile and Prognosis

Vision is one of the essential and important senses of human body. Loss of vision leaves a significant handicap in a person and so it compels the treating physician to analyse and find the potentially treatable cause for...

Evaluation of Inhaler Technique among Patients with Obstructive Airway Diseases – An Observational Study

Abstract: Both asthma and COPD caused significant morbidity and mortality worldwide. Mainstay treatment for both the diseases includes inhalation therapy. But majority of the patients do not use inhalers properly resulti...

Solid Pseudo Papillary Neoplasm of the Pancreas- Rare and Clinically Unexpected: Case Report with Review of Literature

Solid pseudo papillary tumor (SPN) is a unusual primary neoplasm of the pancreas that customarily affects young women. SPN accounts for less than 1% to 2% of exocrine pancreatic tumors. Most common presenting symptom is...

Computed Tomographic Evaluation of Diseases Affecting Paranasal Sinuses

Abstract: The study was carried out in DVVPF Medical College and Hospital, Ahmednagar during a period of one year. In this study, a total of 50 cases were included, which were referred to our department for signs and sym...

Correlation of Umbilical Artery Doppler with placental Histomorphology in FGR

Abstract: Doppler velocimetry (DV) is widely used to assess the vascular formation of the placenta in fetal growth restriction (FGR)and to estimate the haemodynamic condition of the growth-restricted fetus. Umbilical art...

Download PDF file
  • EP ID EP371045
  • DOI -
  • Views 69
  • Downloads 0

How To Cite

Dr Rajul Lodha, Dr Renuka Z Lal, Dr Shweta Biyani (2016). HbA1c as screening biomarker of dyslipidemia in Type 2 Diabetes mellitus patients. Scholars Journal of Applied Medical Sciences, 4(5), 1600-1602. https://www.europub.co.uk/articles/-A-371045